Abstract:Key PointsTwo major classes of ubiquitin ligases, the SKP1–CUL1–F-box-protein (SCF) complex and the anaphase-promoting complex/cyclosome (APC/C), have a central role in cell-cycle regulation.The SCF complex and APC/C are structurally similar. Each is constituted of common subunits and a variable substrate-recognition subunit (F-box proteins for the SCF complex and activators for the APC/C). Three F-box proteins in the SCF complex — S-phase kinase-associated protein 2 (SKP2), F-box and WD-40 domain protein 7 (FBW7) and β-transducin repeat-containing protein (β-TRCP) — and two activators in the APC/C — cell division cycle 20 (CDC20) and CDH1 (also known as HCT1) — are the most important in cell-cycle regulation.SKP2 targets negative regulators of the cell cycle such as p27, p21 and p57 for degradation, and thereby promotes cell-cycle progression during S and G2 phases. SKP2 is upregulated in many human cancers.FBW7 induces the degradation of positive regulators of the cell cycle, such as MYC, JUN, cyclin E and Notch. FBW7 is often mutated in a subset of human cancers.β-TRCP is a versatile F-box protein that recognizes several cell-cycle regulators — EMI1/2, WEE1A and CDC25A/B — in addition to its classical substrates, β-catenin and IκB. In some cancers, β-TRCP mutation or overexpression is found.CDC20 targets securin and mitotic cyclins for destruction, and thereby promotes sister-chromatid separation. CDC20 is the crucial mediator of the spindle checkpoint, which prevents aneuploidy and genomic instability. CDC20 is overexpressed in some cancers, although in others the CDC20 gene is mutated or deleted.CDH1 facilitates exit from M phase and maintains G1 phase by mediating the degradation of mitotic cyclins, non-CDK (cyclin-dependent kinase) mitotic kinases and some regulators of the formation of pre-replicative complexes. Deregulated expression or mutation of CDH1 as well as of most CDH1 targets have been described in human cancers.

Small RING Finger Proteins RBX1 and RBX2 of SCF E3 Ubiquitin Ligases: the Role in Cancer and As Cancer Targets

Recent Insight into the Role of RING-finger E3 Ligases in Glioma

The Characteristics and Roles of Β‐trcp1/2 in Carcinogenesis

An integrative pan-cancer analysis revealing the difference in small ring finger family of SCF E3 ubiquitin ligases

RBX1/ROC1-SCF E3 Ubiquitin Ligase is Required for Mouse Embryogenesis and Cancer Cell Survival

The E3 Ligase Ring1 Targets P53 For Degradation And Promotes Cancer Cell Proliferation And Survival

The Role of Fbxo5 in the Development of Human Malignant Tumors.

Targeting SCF E3 Ligases for Cancer Therapies

Cullin-RING ligases in regulation of autophagy

Role of SKP1-CUL1-F-Box-Protein (SCF) E3 Ubiquitin Ligases in Skin Cancer

The Roles of Cullin-2 E3 Ubiquitin Ligase Complex in Cancer

Cullin-RING Ligases as attractive anti-cancer targets.

RING finger specificity in SCF-driven protein destruction.

SAG/ROC/Rbx/Hrt, a Zinc RING Finger Gene Family: Molecular Cloning, Biochemical Properties, and Biological Functions

RBX1 (RING Box Protein 1) E3 Ubiquitin Ligase is Required for Genomic Integrity by Modulating DNA Replication Licensing Proteins.

Cullin-Ring Ligase 5: Functional Characterization And Its Role In Human Cancers

Functional characterization of SAG/RBX2/ROC2/RNF7, an antioxidant protein and an E3 ubiquitin ligase

Cullin-RING Ligase 5: Functional Characterization and Its Role in Human Cancers.

Genetically Engineered Mouse Models for Functional Studies of SKP1-CUL1-F-box-protein (SCF) E3 Ubiquitin Ligases

RING box protein-1(RBX1), a key component of SCF E3 ligase, induced multiple myeloma cell drug-resistance though suppressing p27

Ubiquitin ligases: cell-cycle control and cancer